Novartis Ag NVS
NYSE NVS
$163.30 -0.39 (-0.24%)
As of: Nov 10, 2026 · 3:59 PM EST

Novartis Ag (NVS) Deferred Taxes (2018 - 2019)

Updated

Novartis Ag's Deferred Taxes came in at $25.77 billion for FY2022, down 26.2% from $34.9 billion in FY2021.

Analysis

Novartis Ag (NVS) Deferred Taxes (2018 - 2019) Analysis & Trends

Going back to FY2017, Novartis Ag's Deferred Taxes data covers 5 years.

  • Deferred Taxes carries a five-year compound annual growth rate of -10.3% (FY2017 to FY2022).
  • The FY2022 figure represents the lowest annual Deferred Taxes in data going back to FY2017.
  • Per Business Quant, earlier years put Deferred Taxes at $34.9 billion in FY2021 (unchanged), $34.9 billion in FY2020 (-16.8%) and $41.97 billion in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -665.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.79 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -56.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -612.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -120.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 202.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -860.00 Mn
10 Vertex Pharmaceuticals 138.78 Bn 110.77 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 33.03 Bn
Dec 31, 2018 43.92 Bn
API Access

Novartis Ag Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=NVS&period=max&api_key=YOUR_API_KEY